Added to YB: 2025-01-06
Pitch date: 2025-01-05
SPRC [bullish]
SciSparc Ltd.
-91.12%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies.
Market Cap
$1.9M
Pitch Price
$20.73
Price Target
N/A
Dividend
N/A
EV/EBITDA
-0.18
P/E
-0.11
EV/Sales
0.65
Sector
Pharmaceuticals
Category
special_situation
Show full summary:
SciSparc Ltd. - $SPRC
SPRC: Acquisition of MitoCareX by N2OFF ($700k cash + $8M shares) imminent. Shared leadership (Amitay Weiss chairs both) suggests insider activity. NASDAQ compliance extension likely. Tiny float (3.59M shares), $5.55M market cap. High-risk, short-term play with potential run-up.
Read full article (4 min)